CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. (Q55066852)
Jump to navigation
Jump to search
scientific article published in January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. |
scientific article published in January 1997 |
Statements
CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. (English)
H Donner
H Rau
P G Walfish
J Braun
T Siegmund
R Finke
J Herwig
K H Usadel
K Badenhoop
1 January 1997
143-146